Search Results - "Dayan, Gustavo"

Refine Results
  1. 1

    Economic Impact of Dengue Illness in the Americas by SHEPARD, Donald S, COUDEVILLE, Laurent, HALASA, Yara A, ZAMBRANO, Betzana, DAYAN, Gustavo H

    “…The growing burden of dengue in endemic countries and outbreaks in previously unaffected countries stress the need to assess the economic impact of this…”
    Get full text
    Journal Article
  2. 2

    Mumps Outbreaks in Vaccinated Populations: Are Available Mumps Vaccines Effective Enough to Prevent Outbreaks? by Dayan, Gustavo H., Rubin, Steven, Plotkin, Stanley

    Published in Clinical infectious diseases (01-12-2008)
    “…Increased reports of mumps in vaccinated populations prompted a review of the performance of mumps vaccines. The effectiveness of prior vaccination with 1 dose…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Safety Overview of a Recombinant Live-Attenuated Tetravalent Dengue Vaccine: Pooled Analysis of Data from 18 Clinical Trials by Gailhardou, Sophia, Skipetrova, Anna, Dayan, Gustavo H, Jezorwski, John, Saville, Melanie, Van der Vliet, Diane, Wartel, T Anh

    Published in PLoS neglected tropical diseases (14-07-2016)
    “…A recombinant live attenuated tetravalent dengue vaccine (CYD-TDV) has been shown to be efficacious in preventing virologically-confirmed dengue disease,…”
    Get full text
    Journal Article
  5. 5

    The history of dengue outbreaks in the Americas by Brathwaite Dick, Olivia, San Martín, José L, Montoya, Romeo H, del Diego, Jorge, Zambrano, Betzana, Dayan, Gustavo H

    “…Dengue is a viral disease usually transmitted by Aedes aegypti mosquitoes. Dengue outbreaks in the Americas reported in medical literature and to the Pan…”
    Get full text
    Journal Article
  6. 6

    The Epidemiology of Dengue in the Americas Over the Last Three Decades: A Worrisome Reality by San Martin, Jose Luis, Brathwaite, Olivia, Zambrano, Betzana, Solorzano, Jose Orlando, Bouckenooghe, Alain, Dayan, Gustavo H, Guzman, Maria G

    “…We have reported the epidemic patterns of dengue disease in the Region of the Americas from 1980 through 2007. Dengue cases reported to the Pan American Health…”
    Get full text
    Journal Article
  7. 7

    Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention by Dayan, Gustavo H, Mohamed, Naglaa, Scully, Ingrid L, Cooper, David, Begier, Elizabeth, Eiden, Joseph, Jansen, Kathrin U, Gurtman, Alejandra, Anderson, Annaliesa S

    Published in Expert review of vaccines (01-11-2016)
    “…Staphylococcus aureus is both a commensal organism and also an important opportunistic human pathogen, causing a variety of community and hospital-associated…”
    Get more information
    Journal Article
  8. 8

    Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City: Randomized Controlled Phase 1 Trial of Safety and Immunogenicity by Poo, Jorge, Galan, Francisco, Forrat, Remi, Zambrano, Betzana, Lang, Jean, Dayan, Gustavo

    Published in The Pediatric infectious disease journal (01-01-2011)
    “…Preliminary results in healthy, young US adults showed that a tetravalent, live-attenuated dengue vaccine (TDV) was safe and immunogenic, but no data are…”
    Get full text
    Journal Article
  9. 9

    Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA by Dayan, Gustavo H, Thakur, Manoj, Boaz, Mark, Johnson, Carol

    Published in Vaccine (17-10-2013)
    “…Highlights • CYD-TDV is a tetravalent candidate dengue vaccine. • Immune response is imbalanced with a reduced dose of serotype 4 antigen. • Our results…”
    Get full text
    Journal Article
  10. 10

    Efficacy after 1 and 2 doses of CYD-TDV in dengue endemic areas by dengue serostatus by Dayan, Gustavo H., Langevin, Edith, Forrat, Remi, Zambrano, Betzana, Noriega, Fernando, Frago, Carina, Bouckenooghe, Alain, Machabert, Tifany, Savarino, Stephen, DiazGranados, Carlos A.

    Published in Vaccine (22-09-2020)
    “…•CYD-TDV was efficacious in dengue seropositives aged ≥ 9 years from dose 1 to M25.•Inter-dose efficacy was similar to that post-dose 3 in seropositives…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥50 years of age by Dayan, Gustavo H, Bevilacqua, Joan, Coleman, Dorothy, Buldo, Aileen, Risi, George

    Published in Vaccine (19-10-2012)
    “…Highlights ► ChimeriVax-WN02 is a live attenuated vaccine for protection against West Nile virus. ► We assessed the immunogenicity and safety of…”
    Get full text
    Journal Article
  13. 13

    Assessment of the long-term efficacy of a dengue vaccine against symptomatic, virologically-confirmed dengue disease by baseline dengue serostatus by Dayan, Gustavo H., Langevin, Edith, Gilbert, Peter B., Wu, Yukun, Moodie, Zoe, Forrat, Rémi, Price, Brenda, Frago, Carina, Bouckenooghe, Alain, Cortes, Margarita, Noriega, Fernando, DiazGranados, Carlos A.

    Published in Vaccine (23-04-2020)
    “…•CYD-TDV efficacy was maintained for up to 6 years in seropositives aged ≥9 years.•Persistent CYD-TDV efficacy was also observed in seropositives aged…”
    Get full text
    Journal Article
  14. 14

    Immunogenicity and safety of a recombinant tetravalent dengue vaccine in children and adolescents ages 9-16 years in Brazil by Dayan, Gustavo H, Garbes, Pedro, Noriega, Fernando, Izoton de Sadovsky, Ana Daniela, Rodrigues, Patricia Marques, Giuberti, Camila, Dietze, Reynaldo

    “…Immunogenicity and safety of a recombinant, live-attenuated, tetravalent dengue disease vaccine (CYD-TDV) was evaluated in children/adolescents in Brazil. In…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Implications of a 2005 Measles Outbreak in Indiana for Sustained Elimination of Measles in the United States by Parker, Amy A, Staggs, Wayne, Dayan, Gustavo H, Ortega-Sánchez, Ismael R, Rota, Paul A, Lowe, Luis, Boardman, Patricia, Teclaw, Robert, Graves, Charlene, LeBaron, Charles W

    Published in The New England journal of medicine (03-08-2006)
    “…In 2005, an outbreak of measles occurred that was traced to a student who had returned home to Indiana from a trip to Romania. At a gathering attended by the…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virus by Dayan, Gustavo H, Pugachev, Konstantin, Bevilacqua, Joan, Lang, Jean, Monath, Thomas P

    Published in Viruses (09-12-2013)
    “…Substantial success has been achieved in the development and implementation of West Nile (WN) vaccines for horses; however, no human WN vaccines are approved…”
    Get full text
    Journal Article Book Review
  19. 19

    Phase II, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Immunogenicity and Safety of a West Nile Virus Vaccine in Healthy Adults by Biedenbender, Rex, Bevilacqua, Joan, Gregg, Anne M., Watson, Mike, Dayan, Gustavo

    Published in The Journal of infectious diseases (01-01-2011)
    “…Background. ChimeriVax-WN02 is a live, attenuated chimeric vaccine for protection against West Nile virus. This Phase II, randomized, double-blind,…”
    Get full text
    Journal Article
  20. 20